InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Guppi00 Free
02/26/14 9:48 AM
profile icon
Chandler_ Free
02/26/14 9:41 AM
profile icon
kookiekook Free
02/26/14 8:28 AM
profile icon
moneycents Free
02/25/14 7:15 PM
profile icon
KingDMC Free
02/25/14 6:31 PM
profile icon
zephyrmm Free
02/25/14 6:29 PM
profile icon
Guppi00 Free
02/25/14 5:40 PM
profile icon
nsomniyak PremiumMember
02/25/14 4:42 PM
profile icon
zephyrmm Free
02/25/14 3:43 PM
profile icon
Guppi00 Free
02/25/14 3:31 PM
profile icon
beachlover Free
02/25/14 3:23 PM
profile icon
stock_risk Free
02/25/14 3:10 PM
profile icon
zephyrmm Free
02/25/14 2:54 PM
profile icon
Danstrader Free
02/25/14 2:47 PM
profile icon
stock_risk Free
02/25/14 2:43 PM
profile icon
Danstrader Free
02/25/14 2:39 PM
profile icon
bullrider2 Free
02/25/14 2:37 PM
profile icon
stock_risk Free
02/25/14 2:24 PM
profile icon
Chandler_ Free
02/25/14 2:18 PM
profile icon
KingDMC Free
02/25/14 2:03 PM
profile icon
stock_risk Free
02/25/14 1:31 PM
profile icon
treeshaker Terminated
02/25/14 1:09 PM
profile icon
KingDMC Free
02/25/14 12:57 PM
profile icon
jacklondon413 Free
02/25/14 12:40 PM
profile icon
Danstrader Free
02/25/14 12:21 PM
profile icon
Danstrader Free
02/25/14 12:19 PM
profile icon
stock_risk Free
02/25/14 12:17 PM
profile icon
KingDMC Free
02/25/14 11:49 AM
profile icon
moneycents Free
02/25/14 11:35 AM
profile icon
stock_risk Free
02/25/14 11:35 AM
profile icon
Guppi00 Free
02/25/14 10:43 AM
profile icon
KingDMC Free
02/25/14 10:35 AM
profile icon
stock_risk Free
02/25/14 10:09 AM
profile icon
jacklondon413 Free
02/25/14 9:57 AM
profile icon
Chandler_ Free
02/25/14 9:40 AM
profile icon
KingDMC Free
02/25/14 9:36 AM
profile icon
Romeo2 Free
02/25/14 9:31 AM
profile icon
jacklondon413 Free
02/24/14 2:07 PM
profile icon
stock_risk Free
02/24/14 2:02 PM
profile icon
moneycents Free
02/24/14 12:54 PM
profile icon
stock_risk Free
02/24/14 12:20 PM
profile icon
TheBossTrader Free
02/24/14 9:01 AM
profile icon
KingDMC Free
02/23/14 10:05 PM

Chelsea Therapeutics Intl Ltd fka CHIP RSS Feed

Followers
82
Posters
310
Posts (Today)
0
Posts (Total)
3033
Created
09/10/07
Type
Free
Moderators



Chelsea Therapeutics International (NASDAQ: CHTP)

Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses to acquire and develop products for the treatment of various human diseases. The company develops prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammatory bowel disease, and cancer. It also develops therapeutic agent for the treatment of neurogenic orthostatic hypotension and related conditions, and diseases. In addition, the company develops platform technologies that consist of a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, and I-3D portfolio, a dihydroorotate dehydrogenase inhibiting compound. Chelsea Therapeutics' product in development includes CH-1504, an orally available molecule for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, psoriatic arthritis, and cancer. The company was incorporated in 2002 and is based in Charlotte, North Carolina.
 

Chelsea has a balanced portfolio of novel therapeutic agents that address disease states that correspond to significant unmet medical need. Investigational product candidates in the Chelsea pipeline include droxidopa, which is being evaluated for its potential use in indications which we believe norepinephrine may play a role, as well as a library of metabolically inert antifolate medications, including two clinical-stage products, CH-4051 and CH-1504, for the treatment of rheumatoid arthritis and other autoimmune diseases.

Behind these late and mid-stage products is a complementary portfolio of dihydroorotate dehydrogenase (DHODH) inhibitors, known as I-3D, which may have applications in treating autoimmune diseases and transplant rejection.



Chelsea News
News

Facts


The Pipeline

 

> Metabolically Inert Antifolates & CH-4051

Antifolates: Presentations and Publications

> I-3D

> Droxidopa

Droxidopa: Presentations and Publications

 

 


www.chelseatherapeutics.com

http://finance.yahoo.com/q/ks?s=CHTP

 





  Monday, 09/28/2009 - Schedule 13G - http://www.irconnect.com/mc/irc/secfilings.mc?cmd=disp&id=6816624&type=HTML

  Tuesday, 09/29/2009 - Schedule 13D - http://www.irconnect.com/mc/irc/secfilings.mc?cmd=disp&id=6818700&type=HTML

Board Info
Posts Today
0
Posts (Total)
3033
Posters
310
Moderators
New Post